18-Fluorodeoxyglucose uptake by positron emission tomography in extraocular muscles of patients with and without graves' ophthalmology

Journal of Ophthalmology

Volumn 2013, Issue , 2013, Pages

  García Rojas, Leonardo ^a   Adame Ocampo, Gloria ^b   Alexánderson, Erick ^b   Tovilla Canales, José Luis ^a  

^a Institute of Ophthalmology Conde de Valenciana   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883743870     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2013/529187     Document Type: Article

References (19)

1. Garrity J. A., Bahn R. S., Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. American Journal of Ophthalmology 2006 142 1 147 153 2-s2.0-33745661418 10.1016/j.ajo.2006.02.047
2. Bahn R. S., Heufelder A. E., Pathogenesis of Graves' ophthalmopathy. New England Journal of Medicine 1993 329 20 1468 1475 2-s2.0-0027365837 10.1056/NEJM199311113292007
3. Bartley G. B., The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmstead County, Minnesota. Transactions of the American Ophthalmological Society 1994 92 477 588 2-s2.0-0028633612
4. Bahn R. S., Graves' Ophthalmopathy. New England Journal of Medicine 2010 362 726 738
5. Pritchard J., Han R., Horst N., Cruikshank W. W., Smith T. J., Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. Journal of Immunology 2003 170 12 6348 6354 2-s2.0-0037942721
6. Dolman P. J., Rootman J., VISA classification for graves orbitopathy. Ophthalmic Plastic and Reconstructive Surgery 2006 22 5 319 324 2-s2.0-33748945035 10.1097/01.iop.0000235499.34867.85
7. Lee A. G., Brazis P. W., Garrity J. A., White M., Imaging for neuro-ophthalmic and orbital disease. American Journal of Ophthalmology 2004 138 5 852 862 2-s2.0-7544230171 10.1016/j.ajo.2004.06.069
8. El-Haddad G., Zhuang H., Gupta N., Alavi A., Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Seminars in Nuclear Medicine 2004 34 4 313 329 2-s2.0-5544258354 10.1053/j.semnuclmed.2004.06.006
9. Finn R. D., The search for consistency in the manufacture of PET radiopharmaceuticals. Annals of Nuclear Medicine 1999 13 6 379 382 2-s2.0-0033370871
10. Zasadny K. R., Wahl R. L., Standardized uptake values of normal tissues at PET with 2-[fluorine-18]- fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction. Radiology 1993 189 3 847 850 2-s2.0-0027367203
11. Osman S., Danpure H. J., The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. International Journal of Radiation Applications and Instrumentation B 1992 19 2 183 190 2-s2.0-0026814613 10.1016/0883-2897(92) 90006-K
12. Forstrom L. A., Mullan B. P., Hung J. C., Lowe V. J., Thorson L. M., 18F-FDG labelling of human leukocytes. Nuclear Medicine Communications 2000 21 7 691 694 2-s2.0-0034230704
13. Ishimori T., Saga T., Mamede M., Kobayashi H., Higashi T., Nakamoto Y., Sato N., Konishi J., Increased 18F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. Journal of Nuclear Medicine 2002 43 5 658 663 2-s2.0-0036252235
14. Kuo P. H., Monchamp T., Deol P., Imaging of inflammation in Graves' ophthalmopathy by positron emission tomography/computed tomography. Thyroid 2006 16 4 419 420 2-s2.0-33646498945 10.1089/thy.2006.16.419
15. Burrell S. C., van den Abbeele A. D., 2-deoxy-2-[F-18]fluoro-D-glucose- positron emission tomography of the head and neck: an atlas of normal uptake and variants. Molecular Imaging and Biology 2005 7 3 244 256 2-s2.0-24744456754 10.1007/s11307-005-4112-z
16. Zincirkeser S., Şahin E., Halac M., Sager S., Standardized uptake values of normal organs on 18F-fluorodeoxyglucose positron emission tomography and computed tomography imaging. Journal of International Medical Research 2007 35 2 231 236 2-s2.0-34249728865
17. Uematsu H., Sadato N., Yonekura Y., Tsuchida T., Nakamura S., Sugimoto K., Waki A., Yamamoto K., Hayashi N., Ishii Y., Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG. Journal of Nuclear Medicine 1998 39 12 2121 2127 2-s2.0-0032422142
18. Nakamura S., Okochi K., Murata Y., Shibuya H., Kurabayashi T., [18F]Fluorodeoxyglucose-PET/CT differentiation between physiological and pathological accumulations in head and neck. Nuclear Medicine Communications 2009 30 7 498 503 2-s2.0-67650330195 10.1097/MNM.0b013e3283299a52
19. Meller J., Strutz F., Siefker U., Scheel A., Sahlmann C. O., Lehmann K., Conrad M., Vosshenrich R., Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI. European Journal of Nuclear Medicine and Molecular Imaging 2003 30 5 730 736 2-s2.0-0037907540